Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways

Molecular and Cellular Endocrinology

Volumn 355, Issue 2, 2012, Pages 201-207

  Alonso Magdalena, Paloma ^a   Ropero, Ana Belén ^a   Soriano, Sergi ^a   García Arévalo, Marta ^a   Ripoll, Cristina ^a   Fuentes, Esther ^a   Quesada, Iván ^a   Nadal, Ángel ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Bisphenol A; Estrogen receptors; Islets of Langerhans

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ADULTHOOD; BINDING AFFINITY; CELL TYPE; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; ESTROGEN ACTIVITY; FOOD PACKAGING; GENETIC TRANSCRIPTION; HUMAN; IN VIVO STUDY; INSULIN RESISTANCE; NEWBORN PERIOD; NONHUMAN; OOCYTE DEVELOPMENT; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENVIRONMENTAL EXPOSURE; ESTRADIOL; ESTROGENS; GENE EXPRESSION; HUMANS; PHENOLS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 84859493333     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.12.012     Document Type: Review

References (95)

1. Alonso-Magdalena P., Laribi O., Ropero A.B., Fuentes E., Ripoll C., Soria B., Nadal A. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ. Health Perspect. 2005, 113:969-977.
2. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 2006, 114:106-112.
3. Alonso-Magdalena P., Ropero A.B., Carrera M.P., Cederroth C.R., Baquie M., Gauthier B.R., Nef S., Stefani E., Nadal A. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 2008, 3:e2069.
4. Andersen H.R., Andersson A.M., Arnold S.F., Autrup H., Barfoed M., Beresford N.A., Bjerregaard P., Christiansen L.B., Gissel B., Hummel R., Jorgensen E.B., Korsgaard B., Le Guevel R., Leffers H., McLachlan J., Moller A., Nielsen J.B., Olea N., Oles-Karasko A., Pakdel F., Pedersen K.L., Perez P., Skakkeboek N.E., Sonnenschein C., Soto A.M., et al. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ. Health Perspect. 1999, 107(Suppl. 1):89-108.
5. Belcher S.M. Rapid signaling mechanisms of estrogens in the developing cerebellum. Brain Res. Rev. 2008, 57:481-492.
6. Belcher S.M., Le H.H., Spurling L., Wong J.K. Rapid estrogenic regulation of extracellular signal- regulated kinase 1/2 signaling in cerebellar granule cells involves a G protein- and protein kinase A-dependent mechanism and intracellular activation of protein phosphatase 2A. Endocrinology 2005, 146:5397-5406.
7. Bulayeva N.N., Watson C.S. Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environ. Health Perspect. 2004, 112:1481-1487.
8. Bulayeva N.N., Gametchu B., Watson C.S. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 2004, 69:181-192.
9. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ. Health Perspect. 2005, 113:391-395.
10. Chambliss K.L., Wu Q., Oltmann S., Konaniah E.S., Umetani M., Korach K.S., Thomas G.D., Mineo C., Yuhanna I.S., Kim S.H., Madak-Erdogan Z., Maggi A., Dineen S.P., Roland C.L., Hui D.Y., Brekken R.A., Katzenellenbogen J.A., Katzenellenbogen B.S., Shaul P.W. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J. Clin. Invest. 2010, 120:2319-2330.
11. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 1993, 101:378-384.
12. Del Prato S., Leonetti F., Simonson D.C., Sheehan P., Matsuda M., DeFronzo R.A. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994, 37:1025-1035.
13. Dodds E.C., Lawson W. Synthetic estrogenic agents without the phenanthrene nucleus. Nature 1936, 137:996.
14. Fang H., Tong W., Perkins R., Soto A.M., Prechtl N.V., Sheehan D.M. Quantitative comparisons of in vitro assays for estrogenic activities. Environ. Health Perspect. 2000, 108:723-729.
15. Filardo E., Quinn J., Pang Y., Graeber C., Shaw S., Dong J., Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007, 148:3236-3245.
16. Frigo D.E., Burow M.E., Mitchell K.A., Chiang T.C., McLachlan J.A. DDT and its metabolites alter gene expression in human uterine cell lines through estrogen receptor-independent mechanisms. Environ. Health Perspect. 2002, 110:1239-1245.
17. Gould J.C., Leonard L.S., Maness S.C., Wagner B.L., Conner K., Zacharewski T., Safe S., McDonnell D.P., Gaido K.W. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol. Cell. Endocrinol. 1998, 142:203-214.
18. Guillette L.J., Gross T.S., Masson G.R., Matter J.M., Percival H.F., Woodward A.R. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ. Health Perspect. 1994, 102:680-688.
19. Gustafsson J.A. What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol. Sci. 2003, 24:479-485.
20. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276:36869-36872.
21. Hammes S.R., Levin E.R. Extranuclear steroid receptors: nature and actions. Endocr. Rev. 2007, 28:726-741.
22. Harrington W.R., Kim S.H., Funk C.C., Madak-Erdogan Z., Schiff R., Katzenellenbogen J.A., Katzenellenbogen B.S. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol. Endocrinol. 2006, 20:491-502.
23. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 2007, 87:905-931.
24. Hewitt S.C., Korach K.S. Estrogenic activity of bisphenol A and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) demonstrated in mouse uterine gene profiles. Environ. Health Perspect. 2011, 119:63-70.
25. Hillier S.G., Whitelaw P.F., Smyth C.D. Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited. Mol. Cell. Endocrinol. 1994, 100:51-54.
26. Hugo E.R., Brandebourg T.D., Woo J.G., Loftus J., Alexander J.W., Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 2008, 116:1642-1647.
27. Jeng Y.J., Watson C.S. Combinations of physiologic estrogens with xenoestrogens alter ERK phosphorylation profiles in rat pituitary cells. Environ. Health Perspect. 2011, 119:104-112.
28. Kang J.H., Kondo F., Katayama Y. Human exposure to bisphenol A. Toxicology 2006, 226:79-89.
29. Kelly M.J., Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 2001, 12:152-156.
30. Krishnan A.V., Stathis P., Permuth S.F., Tokes L., Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993, 132:2279-2286.
31. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
32. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
33. Kurosawa T., Hiroi H., Tsutsumi O., Ishikawa T., Osuga Y., Fujiwara T., Inoue S., Muramatsu M., Momoeda M., Taketani Y. The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type. Endo. J. 2002, 49:465-471.
34. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 2000, 74:311-317.
35. Le H.H., Belcher S.M. Rapid signaling actions of environmental estrogens in developing granule cell neurons are mediated by estrogen receptor ss. Endocrinology 2010, 151:5689-5699.
36. Lebesgue D., Traub M., De Butte-Smith M., Chen C., Zukin R.S., Kelly M.J., Etgen A.M. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS One 2010, 5:e8642.
37. Lee H.J., Chattopadhyay S., Gong E.Y., Ahn R.S., Lee K. Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicol Sci 2003, 75:40-46.
38. Losel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C., Rossol-Haseroth K., Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 2003, 83:965-1016.
39. Marin R., Guerra B., Hernandez-Jimenez J.G., Kang X.L., Fraser J.D., Lopez F.J., Alonso R. Estradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor. Neuroscience 2003, 121:917-926.
40. Markey C.M., Michaelson C.L., Veson E.C., Sonnenschein C., Soto A.M. The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ. Health Perspect. 2001, 109:55-60.
41. Matthews J.B., Twomey K., Zacharewski T.R. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem. Res. Toxicol. 2001, 14:149-157.
42. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E., Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. Embo J. 1996, 15:1292-1300.
43. Nadal A., Ropero A.B., Laribi O., Maillet M., Fuentes E., Soria B. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc. Natl. Acad. Sci. USA 2000, 97:11603-11608.
44. Nadal A., Diaz M., Valverde M.A. The estrogen trinity: membrane, cytosolic, and nuclear effects. News Physiol. Sci. 2001, 16:251-255.
45. Nadal A., Ropero A.B., Fuentes E., Soria B., Ripoll C. Estrogen and xenoestrogen actions on endocrine pancreas: from ion channel modulation to activation of nuclear function. Steroids 2004, 69:531-536.
46. Nadal A., Alonso-Magdalena P., Soriano S., Quesada I., Ropero A.B. The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol. Cell. Endocrinol. 2009, 304:63-68.
47. Nagel S.C., Hagelbarger J.L., McDonnell D.P. Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and Xenobiotics. Endocrinology 2001, 142:4721-4728.
48. Nelson L.R., Bulun S.E. Estrogen production and action. J. Am. Acad. Dermatol. 2001, 45:S116-24.
49. Olea N., Pulgar R., Perez P., Olea-Serrano F., Rivas A., Novillo-Fertrell A., Pedraza V., Soto A.M., Sonnenschein C. Estrogenicity of resin-based composites and sealants used in dentistry. Environ. Health Perspect. 1996, 104:298-305.
50. Pappas T.C., Gametchu B., Watson C.S. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. Faseb J. 1995, 9:404-410.
51. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 1997, 18:306-360.
52. Qiu J., Bosch M.A., Tobias S.C., Grandy D.K., Scanlan T.S., Ronnekleiv O.K., Kelly M.J. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J. Neurosci. 2003, 23:9529-9540.
53. Qiu J., Bosch M.A., Tobias S.C., Krust A., Graham S.M., Murphy S.J., Korach K.S., Chambon P., Scanlan T.S., Ronnekleiv O.K., Kelly M.J. A G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis. J. Neurosci. 2006, 26:5649-5655.
54. Qiu J., Ronnekleiv O.K., Kelly M.J. Modulation of hypothalamic neuronal activity through a novel G-protein-coupled estrogen membrane receptor. Steroids 2008, 73:985-991.
55. Quesada I., Fuentes E., Viso-Leon M.C., Soria B., Ripoll C., Nadal A. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17beta-estradiol rapidly activate transcription factor CREB. Faseb J. 2002, 16:1671-1673.
56. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
57. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., Vandenbergh J.G., Walser-Kuntz D.R., vom Saal F.S. In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 2007, 24:199-224.
58. Roepke T.A., Qiu J., Bosch M.A., Ronnekleiv O.K., Kelly M.J. Cross-talk between membrane-initiated and nuclear-initiated oestrogen signalling in the hypothalamus. J. Neuroendocrinol. 2009, 21:263-270.
59. Ropero A.B., Alonso-Magdalena P., Garcia-Garcia E., Ripoll C., Fuentes E., Nadal A. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int. J. Androl. 2008, 31:194-200.
60. Routledge E.J., White R., Parker M.G., Sumpter J.P. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J. Biol. Chem. 2000, 275:35986-35993.
61. Ruehlmann D.O., Steinert J.R., Valverde M.A., Jacob R., Mann G.E. Environmental estrogenic pollutants induce acute vascular relaxation by inhibiting L-type Ca2+ channels in smooth muscle cells. Faseb J. 1998, 12:613-619.
62. Safe S., Kim K. Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog. Nucleic Acid Res. Mol. Biol. 2004, 77:1-36.
63. Safe S.H., Pallaroni L., Yoon K., Gaido K., Ross S., McDonnell D. Problems for risk assessment of endocrine-active estrogenic compounds. Environ. Health Perspect. 2002, 110(Suppl 6):925-929.
64. Sajiki J., Takahashi K., Yonekubo J. Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 1999, 736:255-261.
65. Saville B., Wormke M., Wang F., Nguyen T., Enmark E., Kuiper G., Gustafsson J.A., Safe S. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J. Biol. Chem. 2000, 275:5379-5387.
66. Sharpe R.M. Is it time to end concerns over the estrogenic effects of bisphenol A?. Toxicol. Sci. 2010, 114:1-4.
67. Sheeler C.Q., Dudley M.W., Khan S.A. Environmental estrogens induce transcriptionally active estrogen receptor dimers in yeast: activity potentiated by the coactivator RIP140. Environ. Perspect. 2000, 108:97-103.
68. Simpson E.R., Clyne C., Rubin G., Boon W.C., Robertson K., Britt K., Speed C., Jones M. Aromatase - a brief overview. Annu. Rev. Physiol. 2002, 64:93-127.
69. Sohoni P., Sumpter J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 1998, 158:327-339.
70. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., Santen R.J. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol. Endocrinol. 2002, 16:116-127.
71. Sonnenschein C., Soto A.M. An updated review of environmental estrogen and androgen mimics and antagonists. J. Steroid Biochem. Mol. Biol. 1998, 65:143-150.
72. Soriano S., Ropero A.B., Alonso-Magdalena P., Ripoll C., Quesada I., Gassner B., Kuhn M., Gustafsson J.A., Nadal A. Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor. Mol. Endocrinol. 2009, 23:1973-1982.
73. Soto A.M., Justicia H., Wray J.W., Sonnenschein C. p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ. Perspect. 1991, 92:167-173.
74. Sumpter J.P., Jobling S. Male sexual development in "a sea of oestrogen". Lancet 1993, 342:124-125.
75. Susiarjo M., Hassold T.J., Freeman E., Hunt P.A. Bisphenol A exposure in utero disrupts early oogenesis in the mouse. PLoS Genet. 2007, 3:e5.
76. Sutter-Dub M.T. Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell the adipocyte and other cell types. Steroids 2002, 67:77-93.
77. Takeuchi T., Tsutsumi O. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem. Biophys. Res. Commun. 2002, 291:76-78.
78. Toran-Allerand C.D. Minireview: a plethora of estrogen receptors in the brain: where will it end?. Endocrinology 2004, 145:1069-1074.
79. Valverde M.A., Rojas P., Amigo J., Cosmelli D., Orio P., Bahamonde M.I., Mann G.E., Vergara C., Latorre R. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 1999, 285:1929-1931.
80. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 2009, 30:75-95.
81. Vandenberg L.N., Chahoud I., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ. Health Perspect. 2010, 118:1051-1054.
82. vom Saal F.S., Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect. 2005, 113:926-933.
83. Watson C.S., Pappas T.C., Gametchu B. The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environ. Health Perspect. 1995, 103(Suppl 7):41-50.
84. Watson C.S., Bulayeva N.N., Wozniak A.L., Finnerty C.C. Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens, and phytoestrogens. Steroids 2005, 70:364-371.
85. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., vom Saal F.S. Large effects from small exposures I Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 2003, 111:994-1006.
86. Wetherill Y.B., Akingbemi B.T., Kanno J., McLachlan J.A., Nadal A., Sonnenschein C., Watson C.S., Zoeller R.T., Belcher S.M. In vitro molecular mechanisms of bisphenol A action. Reprod. Toxicol. 2007, 24:178-198.
87. Wong J.K., Le H.H., Zsarnovszky A., Belcher S.M. Estrogens and ICI182,780 (Faslodex) modulate mitosis and cell death in immature cerebellar neurons via rapid activation of p44/p42 mitogen-activated protein kinase. J. Neurosci. 2003, 23:4984-4995.
88. Wozniak A.L., Bulayeva N.N., Watson C.S. Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ. Health Perspect. 2005, 113:431-439.
89. http://www.epa.gov/iris/subst/0356.htm, U.E.P.A.
90. http://www.merriam-webster.com/medlineplus/estrogen, M.D.o.t.,U.N.L.M.
91. http://cerhr.niehs.nih.gov/.
92. Zhang C., Kelly M.J., Ronnekleiv O.K. 17Beta-estradiol rapidly increases K(ATP) activity in GnRH via a protein kinase signaling pathway. Endocrinology 2010, 151:4477-4484.
93. Zoeller R.T. Environmental chemicals as thyroid hormone analogues: new studies indicate that thyroid hormone receptors are targets of industrial chemicals?. Mol. Cell. Endocrinol. 2005, 242:10-15.
94. Zoeller R.T., Bansal R., Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 2005, 146:607-612.
95. Zsarnovszky A., Le H.H., Wang H.S., Belcher S.M. Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 2005, 146:5388-5396.